Jan R Kraehling1, Zhengrong Hao1, Monica Y Lee1, David J Vinyard1, Heino Velazquez1, Xinran Liu1, Radu V Stan1, Gary W Brudvig1, William C Sessa1. 1. From the Vascular Biology and Therapeutics Program (J.R.K., Z.H., M.Y.L., W.C.S.) and Department of Pharmacology (J.R.K., Z.H., M.Y.L., W.C.S.), Yale University School of Medicine, New Haven, CT; Department of Chemistry, Yale University, New Haven, CT (D.J.V., G.W.B.); Department of Internal Medicine, VA Connecticut Healthcare System, West Haven, CT (H.V.); Department of Cell Biology, Yale University, School of Medicine, New Haven, CT (X.L.); and Department of Pathology, Dartmouth Medical School, Lebanon, NH (R.V.S.).
Abstract
RATIONALE: Caveolin-1 (Cav-1) negatively regulates endothelial nitric oxide (NO) synthase-derived NO production, and this has been mapped to several residues on Cav-1, including F92. Herein, we reasoned that endothelial expression of an F92ACav-1 transgene would let us decipher the mechanisms and relationships between caveolae structure and intracellular signaling. OBJECTIVE: This study was designed to separate caveolae formation from its downstream signaling effects. METHODS AND RESULTS: An endothelial-specific doxycycline-regulated mouse model for the expression of Cav-1-F92A was developed. Blood pressure by telemetry and nitric oxide bioavailability by electron paramagnetic resonance and phosphorylation of vasodilator-stimulated phosphoprotein were determined. Caveolae integrity in the presence of Cav-1-F92A was measured by stabilization of caveolin-2, sucrose gradient, and electron microscopy. Histological analysis of heart and lung, echocardiography, and signaling were performed. CONCLUSIONS: This study shows that mutant Cav-1-F92A forms caveolae structures similar to WT but leads to increases in NO bioavailability in vivo, thereby demonstrating that caveolae formation and downstream signaling events occur through independent mechanisms.
RATIONALE: Caveolin-1 (Cav-1) negatively regulates endothelial nitric oxide (NO) synthase-derived NO production, and this has been mapped to several residues on Cav-1, including F92. Herein, we reasoned that endothelial expression of an F92ACav-1 transgene would let us decipher the mechanisms and relationships between caveolae structure and intracellular signaling. OBJECTIVE: This study was designed to separate caveolae formation from its downstream signaling effects. METHODS AND RESULTS: An endothelial-specific doxycycline-regulated mouse model for the expression of Cav-1-F92A was developed. Blood pressure by telemetry and nitric oxide bioavailability by electron paramagnetic resonance and phosphorylation of vasodilator-stimulated phosphoprotein were determined. Caveolae integrity in the presence of Cav-1-F92A was measured by stabilization of caveolin-2, sucrose gradient, and electron microscopy. Histological analysis of heart and lung, echocardiography, and signaling were performed. CONCLUSIONS: This study shows that mutant Cav-1-F92A forms caveolae structures similar to WT but leads to increases in NO bioavailability in vivo, thereby demonstrating that caveolae formation and downstream signaling events occur through independent mechanisms.
Authors: M Drab; P Verkade; M Elger; M Kasper; M Lohn; B Lauterbach; J Menne; C Lindschau; F Mende; F C Luft; A Schedl; H Haller; T V Kurzchalia Journal: Science Date: 2001-08-09 Impact factor: 47.728
Authors: Adrian R Jaszewski; Yang C Fann; Yeong Renn Chen; Keizo Sato; Jean Corbett; Ronald P Mason Journal: Free Radic Biol Med Date: 2003-08-15 Impact factor: 7.376
Authors: B Razani; J A Engelman; X B Wang; W Schubert; X L Zhang; C B Marks; F Macaluso; R G Russell; M Li; R G Pestell; D Di Vizio; H Hou; B Kneitz; G Lagaud; G J Christ; W Edelmann; M P Lisanti Journal: J Biol Chem Date: 2001-07-16 Impact factor: 5.157
Authors: Marta H Krieger; Annarita Di Lorenzo; Christine Teutsch; Katalin Kauser; William C Sessa Journal: Lab Invest Date: 2010-06-28 Impact factor: 5.662
Authors: Takuya Hashimoto; Toshihiko Isaji; Haidi Hu; Kota Yamamoto; Hualong Bai; Jeans M Santana; Andrew Kuo; Go Kuwahara; Trenton R Foster; Jesse J Hanisch; Bogdan A Yatsula; William C Sessa; Katsuyuki Hoshina; Alan Dardik Journal: Arterioscler Thromb Vasc Biol Date: 2019-04 Impact factor: 8.311
Authors: Daniel J DelloStritto; Pritam Sinharoy; Patrick J Connell; Joseph N Fahmy; Holly C Cappelli; Charles K Thodeti; Werner J Geldenhuys; Derek S Damron; Ian N Bratz Journal: Free Radic Biol Med Date: 2016-09-25 Impact factor: 7.376
Authors: Yunhui Du; Rui Li; Wayne Bigond Lau; Jianli Zhao; Bernard Lopez; Theodore A Christopher; Xin-Liang Ma; Yajing Wang Journal: PLoS One Date: 2016-03-29 Impact factor: 3.240
Authors: Chinnaswamy Tiruppathi; Sushil C Regmi; Dong-Mei Wang; Gary C H Mo; Peter T Toth; Stephen M Vogel; Radu V Stan; Mark Henkemeyer; Richard D Minshall; Jalees Rehman; Asrar B Malik Journal: Mol Biol Cell Date: 2020-04-02 Impact factor: 4.138